Saik Andrew
- SEC CIK
- 0001616284
In the past year, 3 open-market sale filings worth $218.2K and no purchases.
Current role at each company
- ARVN Arvinas, Inc.Chief Financial Officeras of Jun 24, 2026
- MIST Milestone Pharmaceuticals Inc.Directoras of Jun 12, 2026
- ICPT Intercept Pharmaceuticals, Inc.EVP & Chief Financial Officeras of Nov 13, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $218.2K
- 3 filings
- Net
- −$218.2K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Saik Andrew as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ARVN Arvinas, Inc.
Chief Financial Officer4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 24, 2026 (view filing) | Jun 24 | Same day | Saik AndrewChief Financial Officer | SSale | −5.70K | $8.16 | −$46.5K | −2.9%187.4K after | 10b5-1 |
| May 13, 2026 (view filing) | May 11 | 2 days | Saik AndrewChief Financial Officer | SSale | −11.1K | $9.94 | −$110.7K | −5.5%193.1K after | |
| Feb 18, 2026 (view filing) | Feb 13 | 5 days | Saik AndrewChief Financial Officer | SSale | −5.13K | $11.89 | −$61.0K | −3.1%159.3K after | |
| Jun 24, 2025 (view filing) | Jun 24 | Same day | Saik AndrewChief Financial Officer | SSale | −5.70K | $7.61 | −$43.4K | −3.4%164.4K after |